Dr. Eadens is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2045 N Franklin St
Denver, CO 80205Phone+1 303-338-4545
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013
- University of ColoradoResidency, Internal Medicine, 2006 - 2009
- University of Florida College of MedicineClass of 2006
Certifications & Licensure
- CO State Medical License 2012 - 2025
- MN State Medical License 2009 - 2013
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 421 citationsPhase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Fact...Jennifer L. Spratlin, Roger B. Cohen, Matthew Eadens, Lia Gore, D. Ross Camidge
Journal of Clinical Oncology. 2010-02-10 - 117 citationsCurrent Status of Src Inhibitors in Solid Tumor MalignanciesLauren Puls, Matthew J Eadens, Wells A. Messersmith
The Oncologist. 2011-05-01 - 38 citationsA phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.Tufia C. Haddad, Rui Qin, Ruth Lupu, Daniel Satele, Matthew J Eadens
Cancer Chemotherapy and Pharmacology. 2017-05-05
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: